Generic for Amphetamine-Dextroamphetamine Extended Release: An Overview
Adderall and amphetamine-
dextroamphetamine extended release are manufactured by Shire US, Inc. Adderall (but not amphetamine-dextroamphetamine extended release) is off patent and is available as a generic.
Amphetamine-dextroamphetamine extended release is currently protected by a patent that prevents any generic version from being manufactured. Yet, if you search the Internet for "generic amphetamine-dextroamphetamine extended release," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. You should not buy any generic amphetamine-dextroamphetamine extended release until there is an approved generic available.
When Will There Be a Generic Amphetamine-Dextroamphetamine Extended Release?
The first patent for amphetamine-dextroamphetamine extended release currently expires in 2018.
This is the earliest date that a generic version could become available. However, there are other circumstances that could come up to extend the exclusivity period beyond 2018. This could include things such as lawsuits or other patents for specific amphetamine-dextroamphetamine extended release uses. Once amphetamine-dextroamphetamine extended release goes off patent, there may be several companies that manufacture a generic version.